Here’s a roundup of recent Triangle-related tech and life science news as reported by other publications:

  • Get Spiffy expands to Atlanta- eyes more growth

“Get Spiffy, the startup brainchild of car wash entrepreneur Karl Murphy of Carolina Auto Spa and ChannelAdvisor chairman and co-founder Scot Wingo, is expanding,” reports the Triangle Business Journal.

Read the details at:

http://www.bizjournals.com/triangle/blog/techflash/2016/08/wingo-backed-car-wash-app-expands-to-atlanta.html

  • ChannelAdvisor revenue up; so are losses

“E-commerce technology ChannelAdvisor generated a 12.1 percent increase in revenue but posted a slightly larger net loss in the second quarter,” says The News and Observer.

Read more at:

http://www.newsobserver.com/news/business/article93788962.html#storylink=cpy

  • Beat the heat with N.C. startups

“Here are a few cool local businesses whose products can help us beat, ignore or even enjoy this late summer steaminess,” reports ExitEvent.

Among the featured firms:

  • Brewsees
  • MATI Energy
  • Stealz

Get the details at:

http://exitevent.com/article/beat-the-heat-with-11-nc-startups-160802

  • BioCryst drops experimental drug

“Durham drug maker BioCryst Pharmaceuticals is abandoning an experimental drug, avoralstat, which earlier this year failed to meet expectations in a clinical trial,” the N&O reports.

Read more at:

http://www.newsobserver.com/news/business/article93683412.html#storylink=cpy

  • Breaking down LabCorp-Sequenom deal

LabCorp’s announced by of Sequenom last week is broken down by xConomy.

“Sequenom is no stranger to North Carolina, where it had a presence until earlier this year. In 2011, state incentives lured the company to Research Triangle Park, where it built a $19 million lab to bolster its molecular diagnostics business. The company said the North Carolina site would expand its reach in genetic testing. The lab processed the company’s prenatal tests and reproductive health tests, including a Down syndrome diagnostic that tests fetal DNA circulating in the mother’s bloodstream,” xComoy reports.

Read the story at:

LabCorp Boosts Prenatal Testing Presence with $371M Sequenom Deal